This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Neurology  • Multiple Sclerosis/ Demyelinating Disease  • Immunology  • Immunologic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Thomas L. Delbanco, MD; Erin E. Hartman, MS
From the Division of General Medicine, Beth Israel Deaconess Medical Center, 330 Brookline Ave, LY318, Boston, MA 02215.

JAMA. 1999;281:2329.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In June 1998, at Neurology Grand Rounds, Richard A. Rudick, MD, discussed treatment for a young man with a 14-month history of multiple sclerosis.¹ The patient's symptoms had manifested primarily with weakness in both legs. Dr Rudick discussed the treatment options for the patient, focusing on whether, when, and how to initiate therapy for patients with recent onset of disease. We asked the patient and his physician to comment on the year that has passed.

MR J, THE PATIENT

Things are going well. My work and marriage are excellent. Last December, I had a relapse over 2 to 3 days, with my left leg becoming paralyzed. My ankle and calf felt rigid, and I needed to use a cane to walk around. My neurologist gave me steroids intravenously for 3 days, and a few days after that I recovered. Now I feel fine. I had another . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?